News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Conference News ESC 2025 Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF Michael O'Riordan August 29, 2025
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
News Daily News AHA Updates Advice for Resuscitation, CV Care After Overdose or Poisons L.A. McKeown September 20, 2023
News ESC 2023 Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST Michael O'Riordan August 27, 2023
News Daily News Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement Todd Neale December 09, 2022
News Daily News Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse Todd Neale January 21, 2022
News Conference News ACC 2021 Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs Todd Neale May 18, 2021
News Daily News How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting Shelley Wood February 26, 2019
News Daily News One in Three Cardiac Patients Use Complementary Health, Often Unbeknownst to Their Doctors Yael L. Maxwell April 05, 2018
News Daily News Heart Rate Changes Over Time Hint at Higher Cardiovascular Risk Michael O'Riordan January 25, 2018
News Daily News NOAC Bleeding Risk Rises With Several Drug Combinations Michael O'Riordan October 06, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Daily News Herbals and the Heart: New Review Seeks to Sum Up Dearth of Data on Effects and Hazards Shelley Wood February 28, 2017
News Daily News AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications Michael O'Riordan October 18, 2016
News Daily News La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular Michael O'Riordan October 18, 2016
News Conference News ESC 2013 New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups Caitlin E. Cox September 03, 2013